Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-n-methyl-5h-benzo(d)naphtho-(2,1b)azepine
2. Sch 39166
3. Sch-39166
4. Sch39166
1. 112108-01-7
2. Sch-39166
3. Ecopipam [inn]
4. Sch 39166
5. Sch39166
6. Chembl298406
7. 0x748o646k
8. 5h-benzo(d)naphth(2,1-b)azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, (6as,13br)-
9. Dsstox_cid_23814
10. Dsstox_rid_80075
11. Dsstox_gsid_43814
12. (-)-(6as,13br)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5h-benzo(d)naphth(2,1-b)azepin-12-ol
13. (6as,13br)-11-chloro-7-methyl-6,6a,7,8,9,13b-hexahydro-5h-benzo[d]naphtho[2,1-b]azepin-12-ol
14. Cas-112108-01-7
15. Ncgc00092362-01
16. Unii-0x748o646k
17. Ecopipam [who-dd]
18. 6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-n-methyl-5h-benzo(d)naphtho(2,1b)azepine
19. 5h-benzo(d)naphth(2,1-b)azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, Trans-(-)-
20. Psyrx-101
21. Gtpl3304
22. Schembl1649794
23. Zinc3897
24. Dtxsid8043814
25. Chebi:93645
26. 11-chloro-7-methyl-5,6a,7,8,9,13b-hexahydro-6h-7-aza-benzo[6,7]cyclohepta[1,2-a]naphthalen-12-ol
27. Tox21_111197
28. Bdbm50004823
29. Tox21_111197_1
30. Db12273
31. (6as,13br)-11-chloro-7-methyl-5,6,6a,8,9,13b-hexahydronaphtho[1,2-a][3]benzazepin-12-ol
32. Ncgc00092362-02
33. Hy-14690
34. Cs-0003511
35. Q5333851
36. Brd-k94270326-004-01-0
37. (6as,13br)-11-chloro-7-methyl-5,6a,7,8,9,13b-hexahydro-6h-7-aza-benzo[6,7]cyclohepta[1,2-a]naphthalen-12-ol
38. Trans-(-) 11-chloro-7-methyl-5,6a,7,8,9,13b-hexahydro-6h-7-aza-benzo[6,7]cyclohepta[1,2-a]naphthalen-12-ol
| Molecular Weight | 313.8 g/mol |
|---|---|
| Molecular Formula | C19H20ClNO |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 313.1233420 g/mol |
| Monoisotopic Mass | 313.1233420 g/mol |
| Topological Polar Surface Area | 23.5 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 403 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
36
PharmaCompass offers a list of Ecopipam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ecopipam manufacturer or Ecopipam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ecopipam manufacturer or Ecopipam supplier.
PharmaCompass also assists you with knowing the Ecopipam API Price utilized in the formulation of products. Ecopipam API Price is not always fixed or binding as the Ecopipam Price is obtained through a variety of data sources. The Ecopipam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ecopipam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ecopipam, including repackagers and relabelers. The FDA regulates Ecopipam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ecopipam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ecopipam supplier is an individual or a company that provides Ecopipam active pharmaceutical ingredient (API) or Ecopipam finished formulations upon request. The Ecopipam suppliers may include Ecopipam API manufacturers, exporters, distributors and traders.
Ecopipam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ecopipam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ecopipam GMP manufacturer or Ecopipam GMP API supplier for your needs.
A Ecopipam CoA (Certificate of Analysis) is a formal document that attests to Ecopipam's compliance with Ecopipam specifications and serves as a tool for batch-level quality control.
Ecopipam CoA mostly includes findings from lab analyses of a specific batch. For each Ecopipam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ecopipam may be tested according to a variety of international standards, such as European Pharmacopoeia (Ecopipam EP), Ecopipam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ecopipam USP).
